Go Pro

Shanghai Fosun Pharmaceutical (Group) (SFOSF) News Today

$1.93 0.00 (0.00%)
As of 09/11/2026 09:34 AM Eastern

Shanghai Fosun Pharmaceutical (Group) Latest News

Shanghai Fosun Pharma Releases 2025 Q3 Report
Is Ardelyx is A Buy After Slip in Early 2022 (SFOSF)
Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them...

Shanghai Fosun Pharmaceutical (Group) Media Mentions By Week

Shanghai Fosun Pharmaceutical (Group) Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SFOSF
News Sentiment

-1.00

0.89

Average
Healthcare
News Sentiment

Shanghai Fosun Pharmaceutical (Group) News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SFOSF Articles
This Week

1

0

SFOSF Articles
Average Week

Shanghai Fosun Pharmaceutical (Group) Trends on MarketBeat

This week vs. last week
Page Views
297
-27%
Get Shanghai Fosun Pharmaceutical (Group) News Delivered to You Automatically

Sign up to receive the latest news and ratings for SFOSF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Shanghai Fosun Pharmaceutical (Group) dated 9/6/2026.
From Our Partners